PLoS Neglected Tropical Diseases (Jul 2024)

Plasmodium vivax genomic surveillance in the Peruvian Amazon with Pv AmpliSeq assay.

  • Johanna Helena Kattenberg,
  • Luis Cabrera-Sosa,
  • Erick Figueroa-Ildefonso,
  • Mathijs Mutsaers,
  • Pieter Monsieurs,
  • Pieter Guetens,
  • Berónica Infante,
  • Christopher Delgado-Ratto,
  • Dionicia Gamboa,
  • Anna Rosanas-Urgell

DOI
https://doi.org/10.1371/journal.pntd.0011879
Journal volume & issue
Vol. 18, no. 7
p. e0011879

Abstract

Read online

BackgroundPlasmodium vivax is the most predominant malaria species in Latin America, constituting 71.5% of malaria cases in 2021. With several countries aiming for malaria elimination, it is crucial to prioritize effectiveness of national control programs by optimizing the utilization of available resources and strategically implementing necessary changes. To support this, there is a need for innovative approaches such as genomic surveillance tools that can investigate changes in transmission intensity, imported cases and sources of reintroduction, and can detect molecular markers associated with drug resistance.Methodology/principal findingsHere, we apply a modified highly-multiplexed deep sequencing assay: Pv AmpliSeq v2 Peru. The tool targets a newly developed 41-SNP Peru barcode for parasite population analysis within Peru, the 33-SNP vivaxGEN-geo panel for country-level classification, and 11 putative drug resistance genes. It was applied to 230 samples from the Peruvian Amazon (2007-2020), generating baseline surveillance data. We observed a heterogenous P. vivax population with high diversity and gene flow in peri-urban areas of Maynas province (Loreto region) with a temporal drift using all SNPs detected by the assay (nSNP = 2909). In comparison, in an indigenous isolated area, the parasite population was genetically differentiated (FST = 0.07-0.09) with moderate diversity and high relatedness between isolates in the community. In a remote border community, a clonal P. vivax cluster was identified, with distinct haplotypes in drug resistant genes and ama1, more similar to Brazilian isolates, likely representing an introduction of P. vivax from Brazil at that time. To test its applicability for Latin America, we evaluated the SNP Peru barcode in P. vivax genomes from the region and demonstrated the capacity to capture local population clustering at within-country level.Conclusions/significanceTogether this data shows that P. vivax transmission is heterogeneous in different settings within the Peruvian Amazon. Genetic analysis is a key component for regional malaria control, offering valuable insights that should be incorporated into routine surveillance.